Intended for UK Healthcare Professionals only. Adverse Event Reporting information can be found at the bottom of the page.
This website contains promotional information

We are committed to supporting patients and clinicians across specialist therapy areas

At MEDICE UK, our innovative approach to medicine means we always look at the needs of clinicians and patients across therapy areas.

A nurse comforting a patient

Our specialist expertise in the UK

We will always strive to deliver solutions that support patients and help them manage the impact of their condition.

ADHD (Attention Deficit Hyperactivity Disorder)

At MEDICE, we have a strong heritage in ADHD therapy. Over the years, we have built our expertise with a deep understanding of the challenges facing patients, clinicians and carers affected by ADHD. We are proud to offer optimised treatment options, solutions and services tailored to individual needs.

Explore the treatments we have available in the UK, for ADHD

Medikinet® XL (methylphenidate hydrochloride)

Learn more

Medikinet® (methylphenidate hydrochloride) tablets

Learn more

Amfexa® (dexamfetamine sulfate)

Learn more

Contact us

If you would like to find out more about our treatments or therapy area expertise, please contact us

Medikinet® XL

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare Professionals are asked to report any suspected adverse reactions via their national reporting system.

Adverse event reporting
Adverse events should be reported. Reporting forms and information can be found at the Yellow Card Scheme; or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should be reported to MEDICE UK at
Please retain the reported medication and packaging for further investigation by MEDICE UK.
Reporting side effects can provide more information on the safety of this medicine.